GlaxoSmithKline share price extends post-Q3 results rally. Jumps 36% in two days
GlaxoSmithKline share price has surged more than 36% in two sessions after the announcement of Q3 results. The stock has ...
GSK rises Tuesday, outperforms market
GSK PLC closed 20.87% below its 52-week high of £18.24, which the company reached on May 16th.
GSK Pharma shares jump 15%, extend gains to 2nd straight day after strong Q3 results
GSK Pharma had reported a consolidated net profit of Rs 230 crore for Q3 FY25. This marks a significant surge of nearly 400 ...
Valeo Financial Advisors LLC Sells 3,907 Shares of GSK plc (NYSE:GSK)
Valeo Financial Advisors LLC lowered its position in GSK plc (NYSE:GSK – Free Report) by 31.8% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and ...
GSK's Strong Performance: Why I'm Upgrading To 'Strong Buy'
GSK's revenue and EPS exceeded my expectations and those of analysts. Check out the reasons why I am upgrading GSK stock's ...
Hosted on MSN1d
Stocks To Watch Today, on Feb 18: Airtel, SBI Cards, RIL, ABB India, BEL, Ajax Engineering, GlaxoSmithKline and others
A late-session recovery helped the 30-share BSE Sensex rise 57.65 points (0.08%) to close at 75,996.86. Earlier in the ...
Business Wire1d
GSK INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that GSK plc Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has bee ...
GlaxoSmithKline Pharmaceuticals shares hit 20% upper circuit as profit jumps fivefold in Q3FY25
GlaxoSmithKline Pharmaceuticals shares surged 20% to ₹2,421.30 after a strong Q3FY25 performance, reporting a 400% rise in ...
GSK INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that GSK plc Investors Have Opportunity to Lead Class Action Lawsuit!
NEW YORK CITY, NY / ACCESS Newswire / February 17, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law ...
Goldman Sachs Reaffirms Their Hold Rating on GlaxoSmithKline (GSK)
Goldman Sachs analyst Rajan Sharma maintained a Hold rating on GlaxoSmithKline (GSK – Research Report) today and set a price target of £16.80.
Billionaire’s hedge fund bets big against the GSK share price!
After years of limping along, the GSK share price has leapt 11% in one month. But one of America's richest investors is ...
Sandur Manganese & Iron Ores Ltd leads gainers in 'A' group
Glaxosmithkline Pharmaceuticals Ltd, Godfrey Phillips India Ltd, Prakash Industries Ltd and Kirloskar Brothers Ltd are among the other gainers in the BSE's 'A' group today, 17 February 2025.